Literature DB >> 6238036

Phosphorylation of high-mobility-group proteins by the calcium-phospholipid-dependent protein kinase and the cyclic AMP-dependent protein kinase.

C Ramachandran, P Yau, E M Bradbury, G Shyamala, H Yasuda, D A Walsh.   

Abstract

Purified lamb thymus high-mobility-group (HMG) proteins 1, 2, and 17 have been investigated as potential substrates for the Ca2+-phospholipid-dependent protein kinase and the cAMP-dependent protein kinase. HMG proteins 1, 2, and 17 are phosphorylated by the Ca2+-phospholipid-dependent protein kinase; the reactions are totally Ca2+ and lipid dependent and are not inhibited by the inhibitor protein of the cAMP-dependent protein kinase. HMG 17 is phosphorylated predominantly in a single seryl residue, Ser 24 in the sequence Gln-Arg-Arg-Ser 24-Ala-Arg-Leu-Ser 28-Ala-Lys, with the second seryl moiety, Ser 28, modified to a markedly lesser degree. HMGs 1 and 2 are also phosphorylated in only seryl residues but with each there are multiple phosphorylation sites. HMG 17, but not HMG 1 or 2, is also phosphorylated by the cAMP-dependent protein kinase with the site phosphorylated being the minor of the two phosphorylated by the Ca2+-phospholipid-dependent protein kinase; the Km for phosphorylation by the cAMP-dependent enzyme is 50-fold higher than that by the Ca2+-phospholipid-dependent enzyme. HMG 17 is an equally effective substrate for the Ca2+-phospholipid-dependent protein kinase either as the pure protein or bound to nucleosomes. Preliminary evidence has indicated that lamb thymus HMG 14 is also a substrate for the Ca2+-phospholipid-dependent enzyme. It is phosphorylated with a Km similar to that of HMG 17 (4-6 microM), and a comparison of tryptic peptides suggests that it is phosphorylated in a site that is homologous with Ser 24 of HMG 17 and distinct from the sites phosphorylated by the cAMP-dependent protein kinase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238036

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  High mobility group proteins and their post-translational modifications.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2008-05-10

2.  Non-histone chromatin proteins in beef thyroid: distinct phosphorylation patterns of several protein kinases.

Authors:  S Levasseur; T Poleck; Y Friedman; G Burke
Journal:  Mol Cell Biochem       Date:  1990-06-25       Impact factor: 3.396

3.  Phosphorylation and subcellular redistribution of high mobility group proteins 14 and 17, analyzed by mass spectrometry.

Authors:  D F Louie; K K Gloor; S C Galasinski; K A Resing; N G Ahn
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

Review 4.  Structure-specific nucleic acid recognition by L-motifs and their diverse roles in expression and regulation of the genome.

Authors:  Roopa Thapar
Journal:  Biochim Biophys Acta       Date:  2015-03-04

5.  Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.

Authors:  Ina Poser; Michaela Golob; Reinhard Buettner; Anja K Bosserhoff
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 6.  HMG modifications and nuclear function.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

7.  Dexamethasone-induced phosphorylation of high mobility group nonhistone proteins of aging rats.

Authors:  S Prasad; M K Thakur
Journal:  Mol Biol Rep       Date:  1987       Impact factor: 2.316

Review 8.  High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.

Authors:  Shunling Yuan; Zhaoping Liu; Zhenru Xu; Jing Liu; Ji Zhang
Journal:  J Hematol Oncol       Date:  2020-07-13       Impact factor: 17.388

Review 9.  Mitochondrial Kinases and the Role of Mitochondrial Protein Phosphorylation in Health and Disease.

Authors:  Veronika Kotrasová; Barbora Keresztesová; Gabriela Ondrovičová; Jacob A Bauer; Henrieta Havalová; Vladimír Pevala; Eva Kutejová; Nina Kunová
Journal:  Life (Basel)       Date:  2021-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.